Nobuyoshi Hanaoka

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML

Kensuke Kojima, Masaya Shimanuki, Masato Shikami et al. · Leukemia · 2008 · 115 citations

Mitochondrial Function, Medicine, P53 Wild-type Aml +10

Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP

Nobuyoshi Hanaoka, Tatsuya Kawaguchi, Kentaro Horikawa et al. · Blood · 2005 · 82 citations

NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease

Nobuyoshi Hanaoka, Bana Jabrì, Zhenpeng Dai et al. · The Journal of Immunology · 2010 · 47 citations · Full text

Radiation Oncology, Cd3ζ Deficiencies, Cancer Immunosurveillance +15

NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes

Nobuyoshi Hanaoka, Hideki Nakakuma, Kentaro Horikawa et al. · British Journal of Haematology · 2009 · 29 citations · Full text

Clinical Immunology, Immunology, Blood Cell +19

Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia

Hiro Tatetsu, Norio Asou, Miki Nakamura et al. · American Journal of Hematology · 2006 · 25 citations